FDA orders new warning about GLP-1's

The FDA says it will require all GLP-1s, the popular weight loss drug, to adjust their warning labels. This is coming after research showed patients on it have increased potential for developing a rare eye condition, which can cause vision loss. FOX's Natalie Chuck has more from Los Angeles.